Katarzyna Gach-Janczak

Dr. Katarzyna Gach-Janczak

Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland
orcid

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2011 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Open access
PDF file
KGKatarzyna Gach-Janczak
Katarzyna Gach-Janczak
AWAnna Wyrębska
Anna Wyrębska
JFJakub Fichna
Jakub Fichna
AJAnna Janecka
Anna Janecka
Morphine is considered the “gold standard” for relieving pain and is currently one of the most effective drugs available clinically for the management of severe pain associated with cancer. In addition to its use in the treatment of pain, morphine appears to be important in the regulation of neoplastic tissue. Although morphine acts directly on the central nervous system to relieve pain, its activities on peripheral tissues are responsible for many of the secondary complications. Therefore, understanding the impact, other than pain control, of morphine on cancer treatment is extremely important. The effect of morphine on tumor growth is still contradictory, as both growth-promoting and growth-inhibiting effects have been observed. Accumulating evidence suggests that morphine can affect proliferation and migration of tumor cells as well as angiogenesis. Various signaling pathways have been suggested to be involved in these extra-analgesic effects of morphine. Suppression of immune system by morphine is an additional complication. This review provides an update on the influence of morphine on the growth and migration potential of tumor cells.

1 June 2012 in Drug Discovery Today
Verified
Journal Article
Closed access
AJAnna Janecka
Anna Janecka
AWAnna Wyrębska
Anna Wyrębska
KGKatarzyna Gach-Janczak
Katarzyna Gach-Janczak
JFJakub Fichna
Jakub Fichna
Tomasz JaneckiTomasz Janecki
Tomasz Janecki

Verified
Journal Article
Open access
PDF file
AJAgata Jaskulska
Agata Jaskulska
AJAnna Janecka
Anna Janecka
KGKatarzyna Gach-Janczak
Katarzyna Gach-Janczak
A sesquiterpene lactone, thapsigargin, is a phytochemical found in the roots and fruits of Mediterranean plants from Thapsia L. species that have been used for centuries in folk medicine to treat rheumatic pain, lung diseases, and female infertility. More recently thapsigargin was found to be a potent cytotoxin that induces apoptosis by inhibiting the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) pump, which is necessary for cellular viability. This biological activity encouraged studies on the use of thapsigargin as a novel antineoplastic agent, which were, however, hampered due to high toxicity of this compound to normal cells. In this review, we summarized the recent knowledge on the biological activity and molecular mechanisms of thapsigargin action and advances in the synthesis of less-toxic thapsigargin derivatives that are being developed as novel anticancer drugs.

6 February 2015 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
KGKatarzyna Gach-Janczak
Katarzyna Gach-Janczak
ADAngelika Długosz
Angelika Długosz
AJAnna Janecka
Anna Janecka

1 November 2008 in Peptides
Verified
Journal Article
Closed access
AJAnna Janecka
Anna Janecka
RSRenata Staniszewska
Renata Staniszewska
KGKatarzyna Gach-Janczak
Katarzyna Gach-Janczak
JFJakub Fichna
Jakub Fichna

20 June 2010 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
KGKatarzyna Gach-Janczak
Katarzyna Gach-Janczak
JSJanusz Szemraj
Janusz Szemraj
AWAnna Wyrębska
Anna Wyrębska
AJAnna Janecka
Anna Janecka